George Rainer Siber

USPTO Granted Patents = 26 (Patent Applications = 4)

CIPO Patents = 4 (Patent Applications = 1)

EPO Patents = 6 (Patent Applications = 10)

Average Co-Inventor Count = 3.2

ph-index = 11

Forward Citations = 323(Granted Patents)

Location History:

Brookline, MA (US) (2007)
Irvington, NY (US) (2002 - 2011)
New York, NY (US) (2010 - 2023)

Company Filing History:

Genocea Biosciences, Inc.

patents

4. 2 out of 1,207

Dana-farber-cancer Institute Inc.

University System of Maryland

patents

7. 1 out of 113

Wyeth Holdings Corporation

patents

where one patent can have more than one assignee

Years Active: 2002-2025

Loading Chart...

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12370247 - Multivalent pneumococcal vaccines (2025-07-29),

2. 12226470 - Pneumococcal dosing regimen (2025-02-18),

3. 11701416 - Multivalent pneumococcal vaccines (2023-07-18),

4. 11612647 - Immunogenic compositions (2023-03-28),

5. 11191830 - Process for preparing pneumococcal polysaccharide-protein conjugates (2021-12-07),

6. 11167020 - Pneumococcal dosing regimen (2021-11-09),

7. 11013793 - Multivalent pneumococcal vaccines (2021-05-25),

8. 10780160 - Process for preparing pneumococcal polysaccharide-protein conjugates (2020-09-22),

9. 10716848 - Process for preparing pneumococcal polysaccharide-protein conjugates (2020-07-21),

10. 10653771 - Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response (2020-05-19),

11. 10406220 - Pneumococcal dosing regimen (2019-09-10),

12. 9981035 - Process for preparing pneumococcal polysaccharide-protein conjugates (2018-05-29),

13. 9895436 - Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response (2018-02-20),

14. 9669084 - Pneumococcal dosing regimen (2017-06-06),

15. 9480736 - Multivalent pneumococcal polysaccharide-protein conjugate composition (2016-11-01),

Title: The Innovative Contributions of George Rainer Siber

Introduction: George Rainer Siber, a distinguished inventor based in New York, NY, has made significant strides in the field of immunology with an impressive portfolio of 25 patents. His innovative work has focused primarily on advancing the prevention and treatment of pneumococcal infections, showcasing his commitment to public health.

Latest Patents: Among Siber's latest patents are groundbreaking methods for immunizing older adults against pneumococcal infections. He developed methods that involve the immunization of naïve adult subjects with a conjugated pneumococcal polysaccharide vaccine. Notably, the initial immunization can be followed by additional doses using either a conjugated or unconjugated pneumococcal polysaccharide vaccine composition. Furthermore, he has worked on multivalent pneumococcal vaccines that present new technologies aimed at preventing and treating these serious infections.

Career Highlights: Throughout his career, George Rainer Siber has been associated with notable companies such as Wyeth and Genocea Biosciences, Inc. His contributions in these organizations have been instrumental in pushing the boundaries of medical research and innovation in vaccine development.

Collaborations: Siber's endeavors in the field often led him to work alongside prominent professionals, including William P. Hausdorff and Peter R. Paradiso. These collaborations have enriched his research and have further amplified the impact of his inventions on public health.

Conclusion: George Rainer Siber's impressive portfolio of patents and his collaborative spirit exemplify his dedication to advancing medical science. His innovative approaches towards immunization against pneumococcal infections have paved the way for enhanced healthcare solutions. As research continues to evolve, the contributions of inventors like Siber remain pivotal in shaping a healthier future.

This text is generated by artificial intelligence and may not be accurate.